These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 25939649)

  • 41. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation.
    Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
    Am J Emerg Med; 2017 Nov; 35(11):1589-1594. PubMed ID: 28551087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not?
    van Veldhuisen DJ; Van Gelder IC; Ahmed A; Gheorghiade M
    Eur Heart J; 2013 May; 34(20):1468-70. PubMed ID: 23324547
    [No Abstract]   [Full Text] [Related]  

  • 43. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.
    Freeman JV; Reynolds K; Fang M; Udaltsova N; Steimle A; Pomernacki NK; Borowsky LH; Harrison TN; Singer DE; Go AS
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):49-58. PubMed ID: 25414270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Digoxin use in atrial fibrillation.
    Ogletree RL
    J Miss State Med Assoc; 2013 Sep; 54(9):258-9. PubMed ID: 24371904
    [No Abstract]   [Full Text] [Related]  

  • 45. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.
    Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Van den Berg MP; Van Gelder IC;
    Heart Rhythm; 2014 Sep; 11(9):1543-50. PubMed ID: 24924587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Digoxin: The good and the bad.
    Ziff OJ; Kotecha D
    Trends Cardiovasc Med; 2016 Oct; 26(7):585-95. PubMed ID: 27156593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Digoxin in Atrial Fibrillation: An Old Topic Revisited.
    Ferrari F; Santander IRMF; Stein R
    Curr Cardiol Rev; 2020; 16(2):141-146. PubMed ID: 31237216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of digoxin in atrial fibrillation: One step further in the mortality controversy from the AFFIRM study.
    Charnigo R; Khairy P; Guo J; Shohoudi A; Elayi CS
    Pacing Clin Electrophysiol; 2018 Jul; 41(7):713-719. PubMed ID: 29660142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is foxglove effective in heart failure?
    Chaggar PS; Shaw SM; Williams SG
    Cardiovasc Ther; 2015 Aug; 33(4):236-41. PubMed ID: 25925484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct; 144(4):597-607. PubMed ID: 12360154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
    J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. When 'digoxin use' is not the same as 'digoxin use': lessons from the AFFIRM trial.
    Murphy SA
    Eur Heart J; 2013 May; 34(20):1465-7. PubMed ID: 23592709
    [No Abstract]   [Full Text] [Related]  

  • 53. A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure.
    Mamas MA; Caldwell JC; Chacko S; Garratt CJ; Fath-Ordoubadi F; Neyses L
    Eur J Heart Fail; 2009 Jul; 11(7):676-83. PubMed ID: 19553398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.
    Karthikeyan G; Devasenapathy N; Zühlke L; Engel ME; Rangarajan S; Teo KK; Mayosi BM; Yusuf S;
    Heart; 2019 Mar; 105(5):363-369. PubMed ID: 30209123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Digitalis therapy associated with increased risk of death].
    Overbeck P
    Herz; 2015 Jun; 40(4):657-8. PubMed ID: 26273713
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
    Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
    Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of digoxin for heart failure and atrial fibrillation in elderly patients.
    Cheng JW; Rybak I
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):419-27. PubMed ID: 21335295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atrial Fibrillation as a Prognostic Indicator in Medium to Large-Sized Dogs with Myxomatous Mitral Valvular Degeneration and Congestive Heart Failure.
    Jung SW; Sun W; Griffiths LG; Kittleson MD
    J Vet Intern Med; 2016; 30(1):51-7. PubMed ID: 26681398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Digoxin in patients with atrial fibrillation and heart failure: A meta-analysis.
    Bavishi C; Khan AR; Ather S
    Int J Cardiol; 2015 Jun; 188():99-101. PubMed ID: 25900519
    [No Abstract]   [Full Text] [Related]  

  • 60. Digoxin use and clinical outcomes in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.
    Guo Y; Kotalczyk A; Wang Y; Lip GYH
    Europace; 2022 Jul; 24(7):1076-1083. PubMed ID: 35025995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.